Advocate Aurora Health, which operates 27 hospitals, said in a statement that the breach may have exposed information including a patients' medical provider, the type of appointment or medical procedure, dates and locations of scheduled appointments, and IP addresses.
A collection of 9 posts
Sailor killed at Pearl Harbor to be laid to rest, at last Free
A 21-year-old sailor from Grayslake will be laid to rest on Tuesday following a decades-long effort to identify remains pulled from Pearl Harbor, more than 80 years after he was killed in the attack that propelled the United States into World War II.
Breach exposed data of half-million Chicago students, staff Free
The FBI and Department of Homeland Security both investigated the breach and the vendor is “monitoring and will continue to monitor the internet in case the data is posted or distributed," CPS said.
Lia Merminga to become Fermilab's new leader Free
Merminga currently serves as the director for the Fermilab's Proton Improvement Plan II, or PIP-II. She said her goal as director will be to successfully see the U.S. lead the way in global particle physics research.
Adler Planetarium announces reopening Free
The famed planetarium on the shores of Lake Michigan will reopen on March 4, joining the ranks of museums and other institutions that have opened their doors once again in recent days months after the pandemic forced them to close.
Chinese Telecom charged with conspiring with former Motorola employees to steal tech Free
The indictment alleges that China-based Hytera Communications Corp., Ltd., recruited and hired Motorola Solutions employees and directed them to take proprietary and trade secret information from Motorola without authorization.
Electric truck maker Rivian goes public Free
Rivian has a contract with Amazon to build 100,000 electric delivery vans at its factory, a former Mitsubishi plant in Normal, Illinois. Amazon.com Inc. owns about 20% of Rivian before accounting for the public offering.
Merck says experimental pill cuts worst effects of COVID-19 Free
Early results showed patients who received the drug, called Molnupiravir, within five days of COVID-19 symptoms had about half the rate of hospitalization and death as patients who received a placebo.